Drug shortage: Methotrexate Sodium Injection (METHOTREXATE)
FDA lists 14 presentations as Current. Availability: Unavailable (4), Limited Availability (2), Available (8). Reason: Other; Demand increase for the drug. Companies: Teva Pharmaceuticals USA, Inc., Hikma Pharmaceuticals USA, Inc., Accord Healthcare Inc., Hospira, Inc., a Pfizer Company, Fresenius Kabi USA, LLC.
- Published by source
- 2023-03-13
- First seen by Reality Radar
- 2026-10-22
- Last verified
- 2026-10-22
Affected
- Manufacturer
- Teva Pharmaceuticals USA, Inc.
- Products
- Methotrexate Sodium Injection METHOTREXATE
Whether your exact unit is affected depends on the model, serial number and region in the official notice.
What the official notice says
Risk: Current — Unavailable
Remedy / actions:
- Estimated recovery: October 2026
- Estimated Recovery: Novemeber 2026
Is this affecting you?
Add what you own or use and Reality Radar will tell you when official changes match it — with evidence and next steps.
Sources
- openFDA Drug Shortages Tier A · official published 2023-03-13
Evidence ledger
Every piece of evidence we store is appended to a public hash chain, so later edits are detectable. Anyone can re-verify it.
| Entry | Kind | Observed | Evidence hash | Entry hash |
|---|---|---|---|---|
| #887 | new | 2026-10-22 | f3026a7d0e65…c32cf8 | 53d6a730047c…b3b582 |
Chain head: #1076 8ad5adc30b9b…88ce20